Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane
Cochrane Evidence Synthesis and Methods · 2023-12 · 1 (10)
DOI: 10.1002/cesm.12031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Evidence Synthesis and Methods, online erschienen am 03.12.2023. Verfasst von Theresa H M Moore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cochrane Editorial and Methods Department London UK. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
RoB 2 is a tool used by systematic reviewers to assess risk of bias in randomized trials. Over a period of 19 months working as editors for Cochrane, we saw many instances where users of RoB 2 frequently applied the tool in ways the developers had not intended, despite availability of detailed guidance, webinars and FAQs.
Methods
In this paper we highlight the ten main issues that we observed, with the aims of optimising the application of the RoB 2 tool, avoiding some of the frequent misapplications of the tool.
Results
Issues noted included failure to state an effect of interest, applying the tool to an entire study rather than to a specific numerical result, omitting key signaling questions and relying on outdated views of causes of bias.
Conclusion
Such omissions and misapplications can lead to overly harsh or lenient assessments of bias with potential to change the confidence we have in an evidence base of randomized trials. We recommend that teams planning to use RoB 2 include at least one member familiar with the RoB 2 detailed guidance and that they use the free resources, such as webinars and FAQs, from the developers of RoB 2 and Cochrane. Our ten tips should be useful to non‐Cochrane systematic reviewers as well as to peer reviewers and editors in Cochrane and other journals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cochrane Editorial and Methods Department London UK.
- NIHR Applied Research Collaboration West (ARC West) University Hospitals Bristol and Weston NHS Foundation Trust Bristol UK.
- Population Health Sciences, Bristol Medical School University of Bristol Bristol UK.
- Liverpool School of Tropical Medicine Liverpool UK.
ORCID-Profile: Theresa H M Moore
Zitieren
APA
Moore, T. H. M., Higgins, J. P. T., & Dwan, K. (2023). Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane. Cochrane Evidence Synthesis and Methods, 1(10). https://doi.org/10.1002/cesm.12031
Vancouver
Moore THM, Higgins JPT, Dwan K. Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane. Cochrane Evidence Synthesis and Methods. 2023;1(10). doi:10.1002/cesm.12031
BibTeX
@article{Moore2023,
author = {Moore, Theresa H M and Higgins, Julian P T and Dwan, Kerry},
title = {Ten tips for successful assessment of risk of bias in randomized trials using the RoB 2 tool: Early lessons from Cochrane},
journal = {Cochrane Evidence Synthesis and Methods},
year = {2023},
volume = {1},
number = {10},
doi = {10.1002/cesm.12031}
}
EUVIMED